Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawyers Will Update Judge on Status of Litigation at Case Management Conference Number of Bard PowerPort lawsuits has nearly doubled over past three months, as lawyers prepare to narrow down a group of 24 bellwether cases being prepared for trial. December 3, 2024 Russell Maas Add Your Comments The U.S. District Judge presiding over all federal Bard PowerPort lawsuits will meet today with lawyers involved in the litigation, to discuss the status of the rapidly growing litigation, as lawyers prepare to narrow down a small group of representative claims that are being prepared for the first bellwether trials. The Bard PowerPort is a totally implantable vascular access device (TIVAD), which is used to deliver chemotherapy and other medications directly into a patient’s blood vessel. The device involves an injection port site, where a needle is inserted, as well as a polyurethane catheter tube that delivers the fluid to the body. Unlike other implanted ports, the Bard PowerPort is marketed as a special type of port catheter, which is intended to withstand higher injection pressures for a variety of treatments, such as chemotherapy. However, more than 949 individuals are now pursuing lawsuits alleging that the catheter tubing material was defectively designed, making the Bard PowerPort prone to fracture and migrate throughout the body, as well as allow bacteria to form and cause devastating port catheter infections. The size of the Bard PowerPort litigation has nearly doubled over the past three months, as more individuals and families learn that injuries and complications experienced in recent years may have been the result of a faulty design. Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in lawsuits filed throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established a Bard PowerPort lawsuit MDL in August 2023, which centralized the litigation before U.S. District Judge David G. Campbell in the District of Arizona for coordinated discovery and pretrial proceedings. As part of the management of the litigation, Judge Campbell is scheduled to meet with lawyers today for a Bard PowerPort lawsuit status conference, to review the growth of the litigation and progress with common issue discovery, as well as case-specific discovery in a small group of bellwether claims. According to a joint memorandum (PDF) submitted by the parties on December 2, there are currently at least 879 cases pending in the MDL, with another 64 cases pending in New Jersey state court and 7 cases pending in the Superior Court of Maricopa County, Arizona. This represents a sharp increase from the 467 Bard PowerPort lawsuits the parties reported were pending in August 2024, and the pace of new filings does not appear to be slowing. Bard PowerPort Lawsuit Bellwether Selections Will Be Narrowed Early in the centralized pretrial proceedings, Judge Campbell directed the parties to select 24 Bard PowerPort bellwether cases, which each involve allegations representative of other claims in the litigation. Since July 2024, the parties have been engaged in written discovery in these cases, including the exchange of comprehensive fact sheets containing details about each lawsuit. On December 10, the parties will each exchange a list of five bellwether cases that they designate for automatic inclusion in a Discovery Group, according to the joint status report submitted yesterday. Lawyers will then meet and confer to jointly identify another five cases, and submit a memorandum by December 18, 2024, confirming the total of 15 cases selected to continue further case-specific discovery. According to a Case Management Order #10 (PDF) issued by Judge Campbell in November 2023, those 15 Discovery Group cases will later be narrowed down further to a final group of six claims in March 2025, which will be eligible to go before federal juries, to help gauge the average Bard PowerPort lawsuit payouts that may be awarded. While the outcomes of these early bellwether trials will not have any binding impact on other claims pending in the MDL or state courts, they are expected to have a major impact on future Bard PowerPort lawsuit settlement negotiations, which will be necessary to avoid hundreds of individual claims being set for trial in the coming years. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Bard PowerPort, Bard PowerPort Lawsuit, Catheter Fracture, Catheter Infection, Catheter Migration, Lawsuit Update, PowerPort MDL Find Out If You Qualify for Port Catheter Compensation More Bard PowerPort Lawsuit Stories Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 August 26, 2025 Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth August 8, 2025 Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 July 18, 2025 1 Comments Tanya August 23, 2025 I had the port on the left side, had problems with it. They put it on the right side in my right atrium. Arrhythmias heart attack, infections and it’s still in. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth August 8, 2025
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)